trending Market Intelligence /marketintelligence/en/news-insights/trending/RCdRfS1xm1Y08kVg07xPxw2 content esgSubNav
In This List

GHO Capital exits Caprion Biosciences

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook


GHO Capital exits Caprion Biosciences

London-based specialist healthcare investment adviser GHO Capital Partners LLP, or Global Healthcare Opportunities, sold Caprion Biosciences to Arsenal Capital Partners Inc.

Caprion provides specialized flow cytometry immune monitoring and quantitative mass spectrometry proteomics services to the biopharmaceutical industry.

Arsenal is a middle-market private equity firm investing in specialty industrials and healthcare businesses.